Activation of Interleukin-6/STAT3 in Rat Cholangiocyte Proliferation Induced by Lipopolysaccharide

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Digestive Diseases and Sciences

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-008-0401-0PMID 18649135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of enteral versus parenteral nutrition on LPS-induced sepsis in a rat model.

  2008influential reference
• ROLE OF JANUS KINASE/SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION PATHWAY IN REGULATION OF EXPRESSION AND INFLAMMATION-PROMOTING ACTIVITY OF HIGH MOBILITY GROUP BOX PROTEIN 1 IN RAT PERITONEAL MACROPHAGES

  2007cited by this paper
• Heterogeneity of the intrahepatic biliary epithelium.

  2006cited by this paper
• Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

  2006cited by this paper
• Evaluation of potential Stat3-regulated genes in human breast cancer.

  2005cited by this paper
• Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.

  2005cited by this paper
• Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place.

  2005cited by this paper
• Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.

  2005cited by this paper
• Pathophysiology of cholangiopathies.

  2005cited by this paper
• Regulation and function of trefoil factor family 3 expression in the biliary tree.

  2004cited by this paper
• Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis.

  2004cited by this paper
• Portal tract fibrogenesis in the liver

  2004cited by this paper
• Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion.

  2003cited by this paper
• Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-&agr; antibodies in a standardized murine contact burn model

  2003cited by this paper
• Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.

  2001cited by this paper
• Systemic inflammatory response in acute cholangitis and after subsequent treatment.

  2000cited by this paper
• Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage

  2000cited by this paper
• Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction.

  2000cited by this paper
• The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro.

  2000cited by this paper
• Lipopolysaccharide induces cholangiocyte proliferation via an interleukin‐6–mediated activation of p44/p42 mitogen‐activated protein kinase

  1999cited by this paper
• Improved method for the histochemical demonstration of glucose-6-phosphatase activity

  1978cited by this paper
• HISTOCHEMICAL AND ULTRASTRUCTURAL DEMONSTRATION OF γ-GLUTAMYL TRANSPEPTIDASE ACTIVITY

  1969cited by this paper
• Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity.

  1969cited by this paper
• A methodological study

  1959cited by this paper
• pathogens: bringing

  year unknowncited by this paper

• Transforming growth factor-β1 triggers the proliferation of human cholangiocyte spheroids via interleukin-6-mediated STAT3 signaling

  2025cites this paper
• JMJD3 Promotes Porphyromonas gingivalis Lipopolysaccharide-Induced Th17-Cell Differentiation by Modulating the STAT3-RORc Signaling Pathway

  2022cites this paper
• 5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg/Th17 balance.

  2021cites this paper
• Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.

  2019cites this paper
• RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis

  2019cites this paper
• Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes.

  2017cites this paper
• reverse-transcription quantitative polymerase chain reaction and western blot analyses were used to detect the mRNA and protein expression of EMT markers E-cadherin and vimentin in HIBECs. Decreased mRNA levels of E-cadherin accom-

  2016cites this paper
• Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling.

  2015cites this paper
• Deficiency of G‐protein‐coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis

  2013cites this paper
• Deletion of interleukin‐6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis

  2010cites this paper
• IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro

  2010cites this paper
• Foxa1 and Foxa2 regulate bile duct development in mice.

  2009cites this paper
• Deletion of IL-6 in dnTGF?RII Mice Improves Colitis but Exacerbates Autoimmune Cholangitis

  year unknowncites this paper